Stock comparison
Bruker
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BRKR
Bruker
Market cap
$6.96B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BRKR | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 33F | 71B | UTHR |
| Benjamin Graham | 44D | 76B | UTHR |
| Philip Fisher |
Side-by-side metrics
| Metric | BRKR | UTHR |
|---|---|---|
| Market cap | $6.96B | $24.13B |
| P/E (TTM) | - | 19.2x |
| EV/EBIT | 34.2x | 15.2x |
| ROIC (TTM) | -2.92% | 18.81% |
| Gross margin | 45.56% | 86.58% |
| Net margin | -0.34% | 40.61% |
| Revenue CAGR 5y | 9.19% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BRKR leads on
- P/E (TTM)-vs 19.2x+103%
- Dividend yield0.47%vs 0.0%+100%
UTHR leads on
- ROIC (TTM)18.81%vs -2.92%+116%
More like UTHR
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.